Hare J M, Kim B, Flavahan N A, Ricker K M, Peng X, Colman L, Weiss R G, Kass D A
Department of Medicine, Cardiology Division, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-6568, USA.
J Clin Invest. 1998 Mar 15;101(6):1424-31. doi: 10.1172/JCI1012.
Inhibitory G protein activity (Gi) and nitric oxide (NO) modulate muscarinic-cholinergic (MC) inhibition of cardiac beta-adrenergic inotropic responses. We hypothesized that Gi mediates MC-NO synthase (NOS) signal transduction. Isoproterenol (0.2-0.8 microg/min) and acetylcholine (1 microM) were administered to isolated perfused rat hearts pretreated with saline (controls; n = 8) or pertussis toxin (PT; 30 microg/kg intraperitoneally 3 d before study; n = 20). PT abrogated in vitro ADP-ribosylation of Gi protein alpha subunit(s) indicating near-total decrease in Gi protein function. Isoproterenol increased peak +dP/dt in both control (peak isoproterenol effect: +2, 589+/-293 mmHg/s, P < 0.0001) and PT hearts (+3,879+/-474 mmHg/s, P < 0.0001). Acetylcholine reversed isoproterenol inotropy in controls (108+/-21% reduction of +dP/dt response, P = 0.001), but had no effect in PT hearts. In controls, NG-monomethyl-L-arginine (100 microM) reduced basal +dP/dt, augmented isoproterenol +dP/dt (peak effect: +4,634+/-690 mmHg/s, P < 0.0001), and reduced the MC inhibitory effect to 69+/-8% (P < 0.03 vs. baseline). L-arginine (100 M) had no effect in controls but in PT hearts decreased basal +dP/dt by 1, 426+/-456 mmHg/s (P < 0.005), downward-shifted the isoproterenol concentration-effect curve, and produced a small MC inhibitory effect (27+/-4% reduction, P < 0.05). This enhanced response to NO substrate was associated with increased NOS III protein abundance, and a three- to fivefold increase in in vitro calcium-dependent NOS activity. Neomycin (1 microM) inhibition of phospholipase C did not reverse L-arginine enhancement of MC inhibitory effects. These data support a primary role for Gi in MC receptor signal transduction with NOS in rat heart, and demonstrate regulatory linkage between Gi and NOS III protein levels.
抑制性G蛋白活性(Gi)和一氧化氮(NO)调节毒蕈碱 - 胆碱能(MC)对心脏β - 肾上腺素能变力反应的抑制作用。我们假设Gi介导MC - 一氧化氮合酶(NOS)信号转导。将异丙肾上腺素(0.2 - 0.8微克/分钟)和乙酰胆碱(1微摩尔)给予经生理盐水预处理的离体灌注大鼠心脏(对照组;n = 8)或百日咳毒素(PT;研究前3天腹腔注射30微克/千克;n = 20)。PT消除了Gi蛋白α亚基的体外ADP - 核糖基化,表明Gi蛋白功能几乎完全降低。异丙肾上腺素增加了对照组(异丙肾上腺素峰值效应:+2,589±293 mmHg/s,P < 0.0001)和PT处理心脏(+3,879±474 mmHg/s,P < 0.0001)的峰值 +dP/dt。乙酰胆碱逆转了对照组中异丙肾上腺素的变力作用(+dP/dt反应降低108±21%,P = 0.001),但对PT处理的心脏无影响。在对照组中,NG - 单甲基 - L - 精氨酸(100微摩尔)降低基础 +dP/dt,增强异丙肾上腺素 +dP/dt(峰值效应:+4,634±690 mmHg/s,P < 0.0001),并将MC抑制作用降低至69±8%(与基线相比,P < 0.03)。L - 精氨酸(100微摩尔)在对照组中无作用,但在PT处理的心脏中使基础 +dP/dt降低1,426±456 mmHg/s(P < 0.005),使异丙肾上腺素浓度 - 效应曲线下移,并产生小的MC抑制作用(降低27±4%,P < 0.05)。这种对NO底物增强的反应与NOS III蛋白丰度增加以及体外钙依赖性NOS活性增加三至五倍相关。新霉素(1微摩尔)对磷脂酶C的抑制并未逆转L - 精氨酸对MC抑制作用的增强。这些数据支持Gi在大鼠心脏中MC受体信号转导与NOS之间的主要作用,并证明了Gi与NOS III蛋白水平之间的调节联系。